MHTX
Manhattan Scientifics, Inc. operates as an innovation hub, primarily dedicated to the advancement and market introduction of technologies designed to enhance human life across the United States. The company's specialized efforts are concentrated within the fields of nanotechnology and nanomedicine. Established in 1992 and headquartered in New York City, the firm was formerly known as Grand Enterprises, Inc.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2024 Q2 | -0.00 | $0 | -$17,000 |
| 2024 Q1 | -0.00 | $0 | -$42,000 |
| 2023 Q4 | -0.00 | $2,000 | -$14,000 |
| 2023 Q3 | -0.00 | $0 | -$37,000 |
| 2023 Q2 | -0.00 | $0 | -$64,000 |
| 2023 Q1 | -0.00 | $0 | -$75,000 |
| 2022 Q4 | -0.00 | -$50,000 | -$87,000 |
| 2022 Q3 | -0.00 | $9,000 | -$88,000 |